These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20101010)

  • 41. Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study.
    Nordwall M; Arnqvist HJ; Bojestig M; Ludvigsson J
    Pediatr Diabetes; 2009 May; 10(3):168-76. PubMed ID: 19175900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal function changes in microalbuminuric normotensive type II diabetic patients treated with angiotensin-converting enzyme inhibitors.
    Romero R; Salinas I; Lucas A; Abad E; Reverter JL; Johnston S; Sanmarti A
    Diabetes Care; 1993 Apr; 16(4):597-600. PubMed ID: 8462386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiotensin-converting enzyme gene polymorphism and microvascular complications in Turkish type 2 diabetic patients.
    Araz M; Yilmaz N; Güngör K; Okan V; Kepekci Y; Sükrü Aynacioglu A
    Diabetes Res Clin Pract; 2001 Nov; 54(2):95-104. PubMed ID: 11640993
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Baseline achievement of lipid goals and usage of lipid medications in patients with diabetes mellitus (from the Veterans Affairs Diabetes Trial).
    Meyers CD; McCarren M; Wong ND; Abraira C; Duckworth WC; Kashyap ML;
    Am J Cardiol; 2006 Jul; 98(1):63-5. PubMed ID: 16784922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development and clinical outcomes of pharmacist-managed diabetes care clinics.
    Morello CM; Zadvorny EB; Cording MA; Suemoto RT; Skog J; Harari A
    Am J Health Syst Pharm; 2006 Jul; 63(14):1325-31. PubMed ID: 16809752
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peroxisome proliferator-activated receptor-gamma agonist increases both low-density lipoprotein cholesterol particle size and small high-density lipoprotein cholesterol in patients with type 2 diabetes independent of diabetic control.
    Bavirti S; Ghanaat F; Tayek JA
    Endocr Pract; 2003; 9(6):487-93. PubMed ID: 14715475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peer-led diabetes education programs in high-risk Mexican Americans improve glycemic control compared with standard approaches: a Project Dulce promotora randomized trial.
    Philis-Tsimikas A; Fortmann A; Lleva-Ocana L; Walker C; Gallo LC
    Diabetes Care; 2011 Sep; 34(9):1926-31. PubMed ID: 21775748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical characteristics associated with microalbuminuria in an adult diabetic population.
    Tung P; Ginier P; Levin SR; Hershman JD; Hershman JM
    J Diabet Complications; 1990; 4(1):15-20. PubMed ID: 2141840
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nephroprotective effects of nitrendipine in hypertensive type I and type II diabetic patients.
    Bretzel RG; Bollen CC; Maeser E; Federlin KF
    Am J Kidney Dis; 1993 Jun; 21(6 Suppl 3):53-64. PubMed ID: 8503436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial.
    ; Wing RR
    Arch Intern Med; 2010 Sep; 170(17):1566-75. PubMed ID: 20876408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipoprotein (a) and microvascular disease in type 1 (insulin-dependent) diabetes.
    Winocour PH; Bhatnagar D; Ishola M; Arrol S; Durrington PN
    Diabet Med; 1991 Dec; 8(10):922-7. PubMed ID: 1838043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum lipoprotein(a) is not increased in NIDDM patients with microalbuminuria.
    Girelli A; Cimino A; Rocca L; Salvi A; Spandrio S; Valentini U; Guistina A
    Diabetes Care; 1994 May; 17(5):456-7. PubMed ID: 8062619
    [No Abstract]   [Full Text] [Related]  

  • 53. Hyperuricemia and albuminuria in patients with type 2 diabetes mellitus.
    Bonakdaran S; Hami M; Shakeri MT
    Iran J Kidney Dis; 2011 Jan; 5(1):21-4. PubMed ID: 21189429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum lipids and glucose control: the SEARCH for Diabetes in Youth study.
    Petitti DB; Imperatore G; Palla SL; Daniels SR; Dolan LM; Kershnar AK; Marcovina S; Pettitt DJ; Pihoker C;
    Arch Pediatr Adolesc Med; 2007 Feb; 161(2):159-65. PubMed ID: 17283301
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Significant increase of apolipoprotein B48 levels by a standard test meal in type 2 diabetic patients with nephropathy.
    Yamamoto T; Hirano T; Mori Y; Tokuno A; Nagashima M; Takada M; Morita R; Lee S; Hayashi T; Adachi M
    J Atheroscler Thromb; 2008 Aug; 15(4):199-205. PubMed ID: 18776703
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of clinical pharmacist intervention on diabetes-related outcomes in a military treatment facility.
    Wallgren S; Berry-Cabán CS; Bowers L
    Ann Pharmacother; 2012 Mar; 46(3):353-7. PubMed ID: 22395249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical significance of HbA1c as a marker of circulating lipids in male and female type 2 diabetic patients.
    Ahmad Khan H
    Acta Diabetol; 2007 Dec; 44(4):193-200. PubMed ID: 17786383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy.
    Asakawa H; Tokunaga K; Kawakami F
    J Diabetes Complications; 2000; 14(3):121-6. PubMed ID: 10989319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-high-density lipoprotein cholesterol is associated more closely with albuminuria in Chinese type 2 diabetic patients with normal renal function, compared with traditional lipid parameters.
    Pan J; Gao F; Bao Y; Zhang L; Tu Y; Jia W
    J Clin Lipidol; 2012; 6(4):382-7. PubMed ID: 22836076
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vascular risk factors in Japanese non-insulin-dependent diabetic patients with microalbuminuria.
    Kodama T; Tomiyama T; Ishizaki T; Baba T
    J Diabetes Complications; 1992; 6(2):70-6. PubMed ID: 1611142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.